Literature DB >> 1725443

Functional interaction of lacidipine with calcium channels in vascular smooth muscle.

T Godfraind1, S Salomone.   

Abstract

We investigated the effect of lacidipine on 100-mM K(+)-evoked contractions and on 100-mM K(+)-evoked 45Ca2+ influx in rat aorta. Moreover, we compared the effect of prolonged depolarization on lacidipine inhibition and (+)isradipine inhibition of 100-mM K(+)-evoked contractions and the reversal of this inhibition by washing with a Ca(2+)-free physiological solution or with a Ca(2+)-free 40-mM K+ depolarizing solution. Lacidipine dose-dependently depressed the response to depolarization, and the pattern of inhibition was typical of voltage-dependent dihydropyridines. The concentration-inhibition curves on K(+)-evoked contraction and on K(+)-evoked 45Ca2+ influx were superimposed; the IC50 was 0.09 nM for the former and 0.11 nM for the latter. The inhibitory effect of lacidipine 60 pM or (+)isradipine 60 pM on rat aorta contraction was significantly enhanced when the preparations had been preincubated in the presence of the drugs in a K(+)-rich depolarizing solution. The inhibitory effect of lacidipine 60 pM or (+)isradipine 100 pM on rat aorta contraction was fully reversed after washing with a physiologic solution. When the washout was performed with a 40-mM K+ depolarizing solution, the inhibition was maintained in lacidipine-treated preparations, whereas it was reversed in the (+)isradipine treated ones. We conclude that lacidipine inhibits rat aorta contraction by interacting specifically with voltage-operated Ca2+ channels. Moreover, unlike with (+)isradipine, the complex formed with lacidipine and inactivated Ca2+ channels seems to not dissociate, because the inhibitory effect persisted in spite of removal of the drug from the depolarizing solution in which the arteries were immersed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725443     DOI: 10.1097/00005344-199102001-00001

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.

Authors:  S Salomone; T Godfraind
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

Review 2.  Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.

Authors:  C R Lee; H M Bryson
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

3.  Lacidipine Prevents Scopolamine-Induced Memory Impairment by Reducing Brain Oxido-nitrosative Stress in Mice.

Authors:  Kunal Khurana; Manish Kumar; Nitin Bansal
Journal:  Neurotox Res       Date:  2021-03-15       Impact factor: 3.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.